- Home
- AEE vs WAT Comparison
AEE vs WAT Comparison
Compare AEE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- WAT
- Stock Information
- Founded
- AEE 1901
- WAT 1958
- Country
- AEE United States
- WAT United States
- Employees
- AEE N/A
- WAT N/A
- Industry
- AEE Power Generation
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- AEE Utilities
- WAT Industrials
- Exchange
- AEE Nasdaq
- WAT Nasdaq
- Market Cap
- AEE 25.3B
- WAT 22.5B
- IPO Year
- AEE N/A
- WAT 1995
- Fundamental
- Price
- AEE $90.70
- WAT $376.70
- Analyst Decision
- AEE Buy
- WAT Hold
- Analyst Count
- AEE 13
- WAT 13
- Target Price
- AEE $87.18
- WAT $379.00
- AVG Volume (30 Days)
- AEE 1.3M
- WAT 486.3K
- Earning Date
- AEE 02-20-2025
- WAT 02-04-2025
- Dividend Yield
- AEE 2.97%
- WAT N/A
- EPS Growth
- AEE N/A
- WAT N/A
- EPS
- AEE 4.26
- WAT 10.48
- Revenue
- AEE $7,058,000,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- AEE $5.16
- WAT $0.53
- Revenue Next Year
- AEE $6.14
- WAT $5.65
- P/E Ratio
- AEE $21.31
- WAT $35.96
- Revenue Growth
- AEE N/A
- WAT N/A
- 52 Week Low
- AEE $67.03
- WAT $279.24
- 52 Week High
- AEE $95.69
- WAT $397.02
- Technical
- Relative Strength Index (RSI)
- AEE 52.10
- WAT 52.32
- Support Level
- AEE $86.40
- WAT $354.37
- Resistance Level
- AEE $90.01
- WAT $379.00
- Average True Range (ATR)
- AEE 1.52
- WAT 9.22
- MACD
- AEE -0.08
- WAT -1.66
- Stochastic Oscillator
- AEE 69.02
- WAT 52.34
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves more than 2.4 million electricity customers and more than 900,000 natural gas customers.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.